Internship Program Germany was completed in the period between 19/10 and 23/10 with the support of the Federal Ministry for Economic Cooperation and Development (BMZ) of the Federal Republic of Germany, German Organisation for International Cooperation GIZ, and Konrad Adenauer Foundation.
Due to the global crisis caused by the coronavirus, the Program was carried out online this year. The Program was dedicated to the largest public health crisis – COVID-19, i.e. the response of the German state and Government to the crisis, the role of the German National Academy of Natural Sciences Leopoldina during the pandemic, adaptability of the business sector, political and social activism, power of the individual and of the community for positive changes in the society, as well as responsibility, solidarity and humanity, for which there should be no borders, especially in a moment this difficult for the entire world.

The participants of the Program, final year scholarship owners and master students of the Faculties of Medicine, Pharmacy, Technology, Physical Chemistry, and Chemistry were greeted by Dr Ronald Seeliger, CEO of Hemofarm AD, a member of STADA Group, who spoke on the topic of ‘Turning Crisis into Opportunity’.
COVID-19 has changed the way of life and the world we live in and made us adapt to it. Not only did our lives change, but also the way we work. What this meant for business, strategies and plans and how the employees adapted to all this were some of the questions the Hemofarm Foundation scholarship owners asked Dr Seeliger.